Mathew Stephens
Vertrieb & Marketing bei Endomagnetics Ltd.
Profil
Mathew Stephens is currently working as the Commercial Director at Endomagnetics Ltd.
He started this position in 2016.
Prior to his current role, he worked as the Principal at S.R.A.
Developments Ltd.
Mathew completed his undergraduate degree at the University of Bath.
Aktive Positionen von Mathew Stephens
| Unternehmen | Position | Beginn |
|---|---|---|
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Vertrieb & Marketing | 01.08.2013 |
Ehemalige bekannte Positionen von Mathew Stephens
| Unternehmen | Position | Ende |
|---|---|---|
S.R.A. Developments Ltd.
 S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Corporate Officer/Principal | - |
Ausbildung von Mathew Stephens
| University of Bath | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
S.R.A. Developments Ltd.
S.R.A. Developments Ltd. Medical SpecialtiesHealth Technology S.R.A. The private company is based in Ashburton, UK. Developments Ltd. manufactures medical and dental instruments. | Health Technology |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
